Inhibition of desmoglein-1 by aspirin leads to synthetic lethality of keratinocytes in Shuanghuanglian-induced cutaneous eruption response

Pengwei Zhuang,Lijuan Xie,Yidan Zhang,Yu Yuan,Hui Liu,Chenghao Bi,Huan Zhao,Yubo Li,Yanjun Zhang
DOI: https://doi.org/10.1016/j.toxlet.2021.06.005
IF: 4.271
2021-10-01
Toxicology Letters
Abstract:<p>Cutaneous eruptions caused by the combination of aspirin (ASA) and Shuanghuanglian preparations have attracted widespread attention; however, the underlying mechanism remains unclear. This study aimed to evaluate the potential mechanism of cutaneous eruptions caused by a combination of Shuanghuanglian injection powder (SHL) and ASA <em>in vivo</em> and <em>in vitro</em>. ASA and SHL co-administration induced inflammatory responses in HaCat cells, as evidenced by marked increases in the expression of IL-4 and TNF-α, and the level of apoptosis. Additionally, histopathological investigation of mice skin tissues showed local inflammatory cell infiltration. Western boltting was used to detect the effects of ASA on desmoglein-1 (DSG1) expression; we found that DSG1 expression was down-regulated <em>in vivo</em> and <em>in vitro</em>. Finally, the key components of SHL were administered to HaCat cells with down-regulated DSG1; it was seen that neochlorogenic acid and rutin have a significant effect on HaCat cell apoptosis. These results demonstrate that DSG1 deficiency is a potential cause of cutaneous eruptions caused by the combination of SHL and ASA, and neochlorogenic acid and rutin are the main allergenic components. This study provides a new research strategy for the safety evaluation of integrated traditional Chinese and Western medicine.</p>
toxicology
What problem does this paper attempt to address?